Loading company…
ID 221286043 · FY 2018–2023 · 6 years
Subsidiary of ბ და ნ ინვესტ (100.0%)
საქმიანობის სფერო ჯანდაცვის სხვა საქმიანობები
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 70 | 12 | 4 | 220 | -28 | -201 | nmf |
| Net Cash used in Investing Activities | 0 | 0 | -107 | 0 | 0 | 0 | |
| Free Cash Flow (OCF − Capex proxy) | 70 | 12 | -104 | 220 | -28 | -201 | nmf |
| Net Change in Cash (before FX) | 70 | 12 | -104 | 220 | -28 | -201 | nmf |
| Net Change in Cash (incl. FX) | 70 | 12 | -104 | 220 | -28 | -201 | nmf |
| Cash at Beginning of Year | 46 | 116 | 128 | 24 | 245 | 217 | +36.6% |
| Cash at End of Year | 116 | 128 | 24 | 245 | 217 | 16 | -32.8% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Ownership & directors from companyinfo.ge (public corporate registry).